Biotecnología

Biotecnología

Japan First to Approve Roche’s Ronapreve to Treat COVID-19
22/07/2021 - Full approval is based on a global phase III trial which found casirivimab and imdevimab reduced hospitalization or death by 70%.
TCR2 Therapeutics Appoints Chief Technical Officer
22/07/2021 - Peter Olagunju to oversee process development, manufacturing, quality control and technical operations for the company’s TRuC-T cell programs.
Aptar CSP’s Activ-Film Technology Protects COVID-19 Tests
22/07/2021 - Activ-Film technology protects two new at-home COVID-19 tests that recently received Emergency Use Authorization from the FDA.
Thermo Fisher Scientific Launches Heracell Vios CR CO2 Incubator
22/07/2021 - First-in-market CO2 incubator combines optimal cell growth capabilities with certified cleanroom compatibility.
MOBILion Launches MOBIE HRIM for Biotherapeutic Drug Development
22/07/2021 - Designed to address characterization challenges during biopharmaceutical drug development and quality monitoring.
Pfizer, BioNTech Partner with Biovac for COVID-19 Vax in Africa
22/07/2021 - Biovac will perform manufacturing and distribution activities within Pfizer’s and BioNTech’s global COVID-19 vaccine supply chain and manufacturing network.
Catalent Plans $100M Expansion of Biologics Mfg. Capabilities in Italy
22/07/2021 - Initial phase includes installation of two 2,000-liter single-use bioreactors and associated investments to support early-and late-phase clinical development.
Vetter’s New Clinical Mfg. Site Now Fully Integrated
22/07/2021 - Expands clinical capacity to address growing market demand.
AskBio’s Gene Therapy Gets Fast Track
22/07/2021 - LION-101 is a recombinant adeno-associated virus (rAAV) based vector being developed as a one-time treatment for Limb-Girdle Muscular Dystrophy.
Salk Institute among cross-collaborative teams gifted $220 million by Wu Tsai Human Performance Alliance
22/07/2021 - LA JOLLA—A Salk Institute team led by Professor Satchin Panda, along with teams from five other organizations, have been awarded a total of $220 million by the Joe and Clara Tsai Foundation’s...
UC San Diego among six U.S. institutions in new Wu Tsai Human Performance Alliance
22/07/2021 - UC San Diego is one of six universities invited to participate in the Wu Tsai Human Performance Alliance, a scientific collaboration that aims to transform human health on a global scale through the...
CRO Charnwood Molecular Expands Capabilities
21/07/2021 - $75m construction project in Loughborough creates flexible facility for the growing CRO.
Medable Opens EMEA HQ in Dublin
21/07/2021 - Expands European presence to grow market for decentralized clinical trials.
Vibalogics Advances Growth with Leadership Hires
21/07/2021 - Pharma industry vet Roger Lias joins the CDMO as chief commercial officer.
Daicel Chiral Technologies Opens New Facility in Ann Arbor, MI
21/07/2021 - Also hires new HPLC chemist and promotes sales representative.
Curtana and Catalent Enter Brain Cancer Drug Partnership
21/07/2021 - Sign development and manufacturing agreement for brain cancer drug CT-179.
Eisai, Biogen’s Lecanemab Gets Breakthrough Designation in AD
21/07/2021 - Based on pre-specified analysis showing consistent reduction of clinical decline across several clinical and biomarker endpoints at the highest doses.
Recipharm Invests in Fill Finish Capacity
21/07/2021 - New facility in Uttarakhand, India will increase capacity to 1 billion sterile units per year.
UC San Diego Admits Record 52,946 First-Year and Transfer Students
21/07/2021 - The University of California San Diego received thousands of outstanding applications and has admitted 40,616 first-year and 12,330 transfer undergraduate students for the fall 2021 quarter.
Annual Summer Program for Women in Philosophy Supports the Next Generation of Graduate Students
21/07/2021 - Discussions ranging from reparations to the removal of monuments await the 14 students selected to participate in this year’s Summer Program for Women in Philosophy, the 10-day program organized by...
ExeVir, Mithra CDMO Enter Manufacturing Collaboration
21/07/2021 - Manufacturing of ExeVir's candidate product for Covid-19 Treatments will take place at Mithra CDMO's new injectable facility.